News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
255 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17911)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
PEP-Therapy Reports Positive Results From GLP-Toxicity Study of PEP-010 Drug Candidate
A major step towards clinical trials
May 16, 2019
·
3 min read
Pharm Country
New York Cancer Resource Alliance Presents Awareness and Screening Options to Retired NY Firefighters
Topics included Early Detection & Prevention, getting a SECOND OPINION and the vigilant message of “Get Checked Now!”
May 16, 2019
·
2 min read
Business
Adam Garone Joins Starlight Children’s Foundation As Chief Executive Officer
Starlight Children’s Foundation announced that its Board of Directors has named activist, social entrepreneur, and former Movember Foundation CEO and co-founder Adam Garone as its new Chief Executive Officer.
May 16, 2019
·
3 min read
Deals
Digipath Announces Results for the Fiscal Second Quarter 2019
Revenues Continue to Rise Quarter Over Quarter
May 16, 2019
·
6 min read
Drug Development
Blueprint Medicines Announces Data Presentations at ASCO and EHA Meetings from Registration-Enabling Clinical Trials of Avapritinib and BLU-667 Across Multiple Patient Populations
Blueprint Medicines to Host Investor Event and Webcast at ASCO on Monday, June 3, 2019
May 16, 2019
·
7 min read
Business
Cutting Edge Research from Integra Connect Will be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Leading Provider of Value-based Specialty Care Solutions Selected to Present Research Assessing the Impact of Oncological Treatment Decisions, Care Management Programs on Clinical Outcomes
May 16, 2019
·
3 min read
Biotech Beach
Compulink Previews New User Interface for its Mental Health SMART EHR at APA 2019
Designed by a team of usability experts, the new UI includes an updated look and feel with new fonts, button styles, and colors.
May 16, 2019
·
2 min read
BioMidwest
New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results
Abbott’s ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient (“macros”) ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat
May 16, 2019
·
4 min read
Drug Development
Wellspring Biosciences Announces Clearance of IND Application to Initiate Phase 1 Trial of KRAS G12C Mutant Inhibitor ARS-3248
Wellspring Biosciences, Inc., a wholly owned subsidiary of Araxes Pharma, LLC, announced that the U.S. Food and Drug Administration has cleared an investigational new drug application for ARS-3248, a small molecule KRAS G12C inhibitor.
May 16, 2019
·
3 min read
BioMidwest
3M and Nobel Media Partner to Explore “The Future of Ageing” at Nobel Prize Dialogue, Madrid, May 22
Discussions will range from key questions such as how long we will live in the future to how long we can afford to live and how long we ought to live
May 16, 2019
·
2 min read
Previous
23 of 26
Next